UMIN-CTR Clinical Trial

Public title

Intervention to support survivors of pediatric brain tumor and thier families: A scoping review

Acronym

Intervention to support families of survivors of pediatric brain tumor: A scoping review

Scientific Title

Intervention to support survivors of pediatric brain tumor and thier families: A scoping review

Scientific Title:Acronym

Intervention to support families of survivors of pediatric brain tumor: A scoping review

Region

Japan

Condition

Survivors od pediatric brain tumors

Classification by specialty

Hematology and clinical oncology	Pediatrics	Nursing
Child

Classification by malignancy

Malignancy

Genomic information

NO

Narrative objectives1

The purpose of this scoping review was to identify interventions to support children/survivors with pediatric brain tumors and their families after medical care.

Basic objectives2

Efficacy

Basic objectives -Others

Trial characteristics_1

Trial characteristics_2

Developmental phase

Primary outcomes

Summary of interventions and their effectiveness in supporting children/survivors of pediatric brain tumors who have completed treatment and their families

Key secondary outcomes

Study type

Others,meta-analysis etc

Basic design

Randomization

Randomization unit

Blinding

Control

Stratification

Dynamic allocation

Institution consideration

Blocking

Concealment

No. of arms

Purpose of intervention

Type of intervention

Interventions/Control_1

Interventions/Control_2

Interventions/Control_3

Interventions/Control_4

Interventions/Control_5

Interventions/Control_6

Interventions/Control_7

Interventions/Control_8

Interventions/Control_9

Interventions/Control_10

Age-lower limit

Not applicable

Age-upper limit

Not applicable

Gender

Male and Female

Key inclusion criteria

Interventions to support people up to their 20s diagnosed with childhood brain tumours and whose primary treatment has been completed and their families.
We included studies of interventions for both those children and their families, rather than studies of only children with pediatric brain tumors or only their families.
However, in studies of interventions for children with cancer and their families, studies that included the above subjects were eligible if at least 60% of the study population had pediatric brain tumors.

Key exclusion criteria

Exclusion criteria were applied to publications covering articles focusing exclusively on acute medical care for brain tumors on the admission in the hospital, end-of-life care.
We also excluded interventions that focused solely on neurological outcomes in these children.
This scoping review will be include the only English and Japanese articles, exclude the review studies, conference abstracts, protocols, thesis, letters to the editor and gray literature.

Target sample size

Name of lead principal investigator

1st name	Akemi
Middle name
Last name	Matsuzawa

Organization

Faculty of Health Sciences, Hokkaido University

Division name

Comprehensive Developmental Nursing

Zip code

060-0812

Address

Kita 12, Nishi 5, Kita-ku, Sapporo, Hokkaido, Japan

TEL

0117063378

Email

matsuzawa@hs.hokudai.ac.jp

Name of contact person

1st name	Akemi
Middle name
Last name	Matsuzawa

Organization

Faculty of Health Sciences, Hokkaido University

Division name

Comprehensive Developmental Nursing

Zip code

060-0812

Address

Kita 12, Nishi 5, Kita-ku, Sapporo, Hokkaido, Japan

TEL

0117063378

Homepage URL

Email

matsuzawa@hs.hokudai.ac.jp

Institute

Hokkaido University

Institute

Department

Personal name

Akemi Matsuzawa

Organization

Others

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Co-sponsor

Name of secondary funder(s)

Organization

Faculty of Health Sciences, Hokkaido University

Address

Kita 12, Nishi 5, Kita-ku, Sapporo, Hokkaido, Japan

Tel

0117063378

Email

matsuzawa@hs.hokudai.ac.jp

Secondary IDs

NO

Study ID_1

Org. issuing International ID_1

Study ID_2

Org. issuing International ID_2

IND to MHLW

Institutions

Date of disclosure of the study information

2025

Year

04

Month

26

Day

URL releasing protocol

Publication of results

Unpublished

URL related to results and publications

Number of participants that the trial has enrolled

Results

Results date posted

Results Delayed

Results Delay Reason

Date of the first journal publication of results

Baseline Characteristics

Participant flow

Adverse events

Outcome measures

Plan to share IPD

IPD sharing Plan description

Recruitment status

Main results already published

Date of protocol fixation

2025

Year

04

Month

26

Day

Date of IRB

2025

Year

04

Month

26

Day

Anticipated trial start date

2025

Year

04

Month

26

Day

Last follow-up date

2026

Year

03

Month

31

Day

Date of closure to data entry

Date trial data considered complete

Date analysis concluded

Other related information

This study will use the scoping review(Arksey&O'Malley, 2005). We conduct to five steps for using a five steps in the scopig review are 1)identified research questions, 2) identified relevant studies, 3)selected studies, 4)charted the data, 5)collated/summarized, and reported the findings. We report our review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) extension for scoping reviews (PRISMA ScR)(Tricco et al., 2018).
In accordance with the research questions of this review, English or Japanese articles published in peer reviewed journals, regardless of the year of publication, were searched using four databases: PubMed,CINAHL, Web of Science, and Ichushi Web. However,literature reviews, conference reports, protocol, thesis, and gray literature will be exclude.

Registered date

2025

Year

04

Month

26

Day

Last modified on

2025

Year

07

Month

28

Day

Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065961